References
- Di Bisceglie A. M. Hepatitis C. Lancet 1998; 351: 351–5
- Cahill B. A., Braccia D. Current treatment for hepatocellular carcinoma. Clin J Oncol Nurs 2004; 8: 393–9
- Ren F. Y., Piao X. X., Jin A. L. Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma. World J Gastroenterol 2006; 12: 4656–9
- Bolondi L., Sofia S., Siringo S., Gaiani S., Casali A., Zironi G., et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001; 48: 251–9
- Kim C. K., Lim J. H., Lee W. J. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. J Ultrasound Med 2001; 20: 99–104
- Chalasani N., Horlander J. C., Said A., Hoen H., Kopecky K. K., Stockberger S. M., et al. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 1999; 94: 2988–93
- Wernecke K., Rummeny E., Bongartz G., Vassallo P., Kivelitz D., Wiesmann W., et al. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. Am J Roentgenol 1991; 157: 731–9
- Hosten N., Puls R., Bechstein W. O., Felix R. Focal liver lesions: Doppler ultrasound. Eur Radiol 1999; 9: 428–35
- Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatology 2003; 39: 1076–84
- Albrecht T., Blomley M. J., Burns P. N., Wilson S., Harvey C. J., Leen E., et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003; 227: 361–70
- Quaia E., Calliada F., Rossi S., Garioni L., Rosa L., Pozzi-Mucelli R. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004; 232: 420–30
- Von Herbay A., Vogt C., Willers R., Haussinger D. Real-time imaging with the sonographic contrast agent SonoVue. J Ultrasound Med 2004; 23: 1557–68
- Xu H. X., Liu G. J., Lu M. D., Xie X. Y., Xu Z. F., Zheng Y. L., et al. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 2006; 34: 261–72
- Nicolau C., Brú C. Focal liver lesions: evaluation with contrast-enhanced ultrasonography. Abdom Imaging 2004; 29: 348–59
- Solbiati L., Tonolini M., Cova L., Goldberg S. N. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 2001; 11(Suppl 3)E15–26
- Bruix J., Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208–36
- Kim S. H., Lim H. K., Lee W. J., Cho J. M., Jang H. J. Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 2000; 25: 246–50